Associate Director, Clinical Pathology & Nonclinical Lead

Regeneron Pharmaceuticals Inc.; United States; Remote; USD 176,000 - 287,000; Full time

Benefits offered by this job

Annual bonuses

Equity awards

Pension / retirement benefits

401(k) company match

Health and wellness programs

Paid time off

Family support benefits

Job summary

Regeneron Pharmaceuticals Inc. seeks an Associate Director of Pathology to lead scientific efforts supporting nonclinical drug development, GLP toxicology, and PK studies, across multiple therapeutic focus areas.

The role includes mentoring junior pathologists and coordinating clinical pathology support for TFAs. The candidate will integrate clinical and anatomic pathology data, collaborate with pathologists, toxicologists and CRO partners, and help shape safety strategies across Regeneron’s

Qualifications

• Experience integrating clinical and anatomic pathology data.
• Experience with animal models of human diseases.
• Ability to contribute to cross-functional teams and scientific strategy.

Responsibilities

• Serve as scientific leader supporting nonclinical drug development.
• Interpret pharmacologic and toxicity findings to advance therapeutics.
• Determine and evaluate clinical pathology endpoints in studies.
• Collaborate with anatomic pathologists, toxicologists, and researchers.
• Partner with CROs for scientific peer review of nonclinical safety studies.

Skills

Clinical pathology data integration

Animal models of disease

Cross-functional collaboration

Clear scientific communication

Strategy and problem solving

Education

DVM with ACVP Clinical Pathology

PhD in Pathology/Immunology or related

Job description

Regeneron Pharmaceuticals Inc. seeks an Associate Director of Pathology to lead scientific efforts supporting nonclinical drug development, GLP toxicology, and PK studies, across multiple therapeutic focus areas.

The role includes mentoring junior pathologists and coordinating clinical pathology support for TFAs. The candidate will integrate clinical and anatomic pathology data, collaborate with pathologists, toxicologists and CRO partners, and help shape safety strategies across Regeneron’s